WRF
ALXN
Waddell & Reed Financial’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-20,100
| Closed | -$2.72M | – | 533 |
|
|
2019
Q1 | $2.72M | Sell |
20,100
-16,580
| -45% | -$2.24M | 0.01% | 466 |
|
|
2018
Q4 | $3.57M | Sell |
36,680
-200,005
| -85% | -$19.5M | 0.01% | 459 |
|
|
2018
Q3 | $32.9M | Sell |
236,685
-50,770
| -18% | -$7.06M | 0.07% | 279 |
|
|
2018
Q2 | $35.7M | Sell |
287,455
-596,536
| -67% | -$74.1M | 0.08% | 265 |
|
|
2018
Q1 | $98.5M | Sell |
883,991
-849,020
| -49% | -$94.6M | 0.22% | 115 |
|
|
2017
Q4 | $207M | Sell |
1,733,011
-363,676
| -17% | -$43.5M | 0.46% | 56 |
|
|
2017
Q3 | $294M | Buy |
2,096,687
+438,767
| +26% | +$61.6M | 0.65% | 36 |
|
|
2017
Q2 | $202M | Sell |
1,657,920
-386,146
| -19% | -$47M | 0.44% | 59 |
|
|
2017
Q1 | $248M | Sell |
2,044,066
-1,043,199
| -34% | -$126M | 0.53% | 53 |
|
|
2016
Q4 | $378M | Buy |
3,087,265
+622,286
| +25% | +$76.1M | 0.83% | 26 |
|
|
2016
Q3 | $302M | Buy |
2,464,979
+49,873
| +2% | +$6.11M | 0.63% | 41 |
|
|
2016
Q2 | $282M | Sell |
2,415,106
-138,046
| -5% | -$16.1M | 0.59% | 47 |
|
|
2016
Q1 | $355M | Sell |
2,553,152
-641,892
| -20% | -$89.4M | 0.67% | 39 |
|
|
2015
Q4 | $609M | Sell |
3,195,044
-261,643
| -8% | -$49.9M | 0.99% | 22 |
|
|
2015
Q3 | $541M | Buy |
3,456,687
+1,450,338
| +72% | +$227M | 0.89% | 27 |
|
|
2015
Q2 | $363M | Buy |
2,006,349
+466,222
| +30% | +$84.3M | 0.52% | 58 |
|
|
2015
Q1 | $267M | Buy |
1,540,127
+305,033
| +25% | +$52.9M | 0.37% | 78 |
|
|
2014
Q4 | $229M | Buy |
1,235,094
+90,045
| +8% | +$16.7M | 0.32% | 90 |
|
|
2014
Q3 | $190M | Sell |
1,145,049
-95,076
| -8% | -$15.8M | 0.26% | 99 |
|
|
2014
Q2 | $194M | Sell |
1,240,125
-221,820
| -15% | -$34.7M | 0.28% | 97 |
|
|
2014
Q1 | $222M | Buy |
1,461,945
+147,190
| +11% | +$22.4M | 0.34% | 78 |
|
|
2013
Q4 | $175M | Buy |
1,314,755
+246,339
| +23% | +$32.8M | 0.28% | 97 |
|
|
2013
Q3 | $124M | Buy |
1,068,416
+63,210
| +6% | +$7.34M | 0.24% | 113 |
|
|
2013
Q2 | $92.7M | Buy |
+1,005,206
| New | +$92.7M | 0.19% | 128 |
|